Error loading player: No playable sources found

3495

SSAT Oral Session: Colorectal Diseases II

Date
May 7, 2023
Explore related products in the following collection:

Society: SSAT

Moderators

Speaker Image for Marco Scarpa
Azienda Ospedale Universita Padova
Speaker Image for Brian Bello
MedStar Washington Hospital Center
Speaker Image for Kim Lu
Oregon Health & Science Univ

Related Products

Thumbnail for IMMUNOREACT 10: INFLUENCE OF BMI IN THE IMMUNOLOGICAL MICROENVIRONMENT OF PERITUMORAL HEALTHY MUCOSA IN RECTAL ADENOCARCINOMA
IMMUNOREACT 10: INFLUENCE OF BMI IN THE IMMUNOLOGICAL MICROENVIRONMENT OF PERITUMORAL HEALTHY MUCOSA IN RECTAL ADENOCARCINOMA
INTRODUCTION: Due to its rarity, anal adenocarcinoma (AA) does not have a standardized staging system. The tumor (T) stage of an adenocarcinoma arising from the anal canal could be based on depth of invasion, as for rectal adenocarcinoma, or on size, as in anal squamous cell carcinoma…
Thumbnail for CHARACTERISTICS AND OUTCOMES OF T2 N0 RECTAL ADENOCARCINOMA WITH DEFINITIVE ABDOMINAL RESECTION VERSUS LOCAL EXCISION IN THE ELDERLY (80+ YEARS)
CHARACTERISTICS AND OUTCOMES OF T2 N0 RECTAL ADENOCARCINOMA WITH DEFINITIVE ABDOMINAL RESECTION VERSUS LOCAL EXCISION IN THE ELDERLY (80+ YEARS)
Socioeconomic status (SES) has proven significant impact on colorectal cancer (CRC) outcomes. Lower SES has correlated with increased comorbidities, risk of postoperative complications, and inadequate adherence to treatment guidelines…
Thumbnail for IMMUNOREACT 8: IMMUNE MARKERS AS PREDICTORS OF LOCAL TUMOR SPREAD IN PATIENTS UNDERGOING TRANSANAL EXCISION FOR RECTAL CANCER
IMMUNOREACT 8: IMMUNE MARKERS AS PREDICTORS OF LOCAL TUMOR SPREAD IN PATIENTS UNDERGOING TRANSANAL EXCISION FOR RECTAL CANCER
LUNCH AND TRAINEE JEOPARDY! 12:00 PM - 1:00 PM LEADERSHIP FORUM, NETWORKING SESSION AND ROUNDTABLES 4:00 PM - 5:30 PM KEYNOTE ADDRESS: FUTURE SCENARIO PLANNING TO PREDICT THE FUTURE OF SURGERY 4:00 PM - 4:30 PM